Mobile

Cyclophosphamide and dexamethasone in combination with Ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenolidomide and bortezo...

Update Il y a 5 ans
Reference: ISRCTN58227268

Cyclophosphamide and dexamethasone in combination with Ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenolidomide and bortezomib

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-cyclophosphamide-dexamethasone-and-ixazomib-for-myeloma-muk-8

Inclusion criteria

  • Topic: Cancer; Subtopic: Haematological Oncology; Disease: Myeloma

Links